| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Careplus Health Plans Inc is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sigma Telemed is a York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EōS Fitness is the better gym at the better price. Achieve your fitness goals with group classes, tons of equipment, great amenities, personal training and so much more!
International Medical Equipment, Inc. is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.